Heilinger, Jan https://orcid.org/0009-0004-0026-824X
Roth, Katrin Sabine
Weis, Henning
Fink, Antonis
Weindler, Jasmin
Dietlein, Felix
Krapf, Philipp
Schomäcker, Klaus
Neumaier, Bernd
Dietlein, Markus
Drzezga, Alexander
Kobe, Carsten
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 16 September 2024
Accepted: 15 December 2024
First Online: 10 January 2025
Declarations
:
: The Ethics Commission of the Faculty of Medicine of Cologne University has waived the need for approval. The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All enrolled patients gave written informed consent to participate in this study.
: All enrolled patients gave written informed consent for the publication of this study and its accompanying images.
: A.D. discloses research support from Siemens Healthineers, Life Molecular Imaging, GE Healthcare, AVID Radiopharmaceuticals, SOFIE, Eisai and Novartis/AAA; Speaker Honorary and/or Advisory Boards fees from Siemens Healthineers, Sanofi, GE Healthcare, Biogen, Novo Nordisk, Invicro, Novartis/AAA and Bayer Vital; Stock from Siemens Healthineers, Lantheus Holding; a patent granted for 18 F-PSMA-JK-7 (PSMA-PET imaging tracer). J.H. discloses Advisory Boards fees from Novartis Pharma GmbH.